Stem Cell Alter Egos

Researchers show that cancer stem cells can exist in two distinct and interconvertible states.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

TWO-FACED: The invasive edge of a tumor (left) harbors mesenchymal-like breast cancer stem cells (green), while the interior of the tumor (right) contains epithelial-like cancer stem cells (pink).REPRINTED FROM S. LIU ET AL., STEM CELL REPORTS, 2:78-91, 2014

The paper S. Liu et al., “Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts,” Stem Cell Reports, 2:78-91, 2014. The states Cancer metastasis is thought to rely on tumor cells losing their polarity and their connections with neighbors, enabling them to migrate and invade other tissues—an epithelial-to-mesenchymal transition. The reverse process—the mesenchymal-to-epithelial transition—then allows cells to set up shop in a new tissue. Cancer stem cells can express genes associated with both pathways, but there have been conflicting findings about the relationship between stemness and these transitions. The finding Cancer biologist Max Wicha of the University of Michigan and colleagues showed that breast cancer stem cells (BCSCs) in the same tumor can exist in both states. They found ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies